Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine?

Journal of Biomolecular Structure and Dynamics

Volumn 31, Issue 11, 2013, Pages 1219-1235

  Chen, Kuan Chung ^a   Chang, Su Sen ^b   Tsai, Fuu Jen ^a,c   Chen, Calvin Yu Chian ^a,b,c,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

Author keywords

docking; insulin degrading enzyme (IDE); molecular dynamics (MD); traditional Chinese medicine (TCM); type 2 diabetes mellitus

Indexed keywords

10 HYDROXY OCTADECENOIC ACID; 9 HYDROXY OCTADECENOIC ACID; CATHINONE; DIHYDROCAFFEIC ACID; ENZYME INHIBITOR; INSULIN; INSULINASE; ISOPRAEROSIDE IV; N ETHYLMALEIMIDE; PALMITIC ACID; PENTADECANOIC ACID; POLYGALATENOSIDES D; SCOPOLIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; CHINESE; CHINESE MEDICINE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG IDENTIFICATION; DRUG METABOLISM; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME INHIBITION; ETHNICITY; HYDROGEN BOND; INSULIN DEGRADATION; MOLECULAR DYNAMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; BINDING SITES; CAFFEIC ACIDS; COUMARINS; DIABETES MELLITUS, TYPE 2; GLUCOSIDES; HUMANS; HYDROGEN BONDING; HYPOGLYCEMIC AGENTS; INSULYSIN; MEDICINE, CHINESE TRADITIONAL; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84885612696     PISSN: 07391102     EISSN: 15380254     Source Type: Journal    
DOI: 10.1080/07391102.2012.732340     Document Type: Article

References (61)

1. Behl, M., Zhang, Y., & Zheng, W. (2009). Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure. Cerebrospinal Fluid Research, 6, 11.
2. Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983). CHARMM: A program for macromolecular energy minimization and dynamics calculations. Journal of Computational Chemistry, 4, 187-217
3. Chang, Y. C., Chang, T. J., Jiang, Y. D., Kuo, S. S., Lee, K. C., Chin, K. C., & Chuang, L. M. (2007). Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the chinese population. Diabetes, 56, 2631-2637
4. Chang, T. T., Chen, K. C., Chang, K. W., Chen, H. Y., Tsai, F. J., Sun, M. F., & Chen, C. Y. C. (2011). In silico pharmacology suggests ginger extracts may reduce stroke risks. Molecular Biosystems, 7, 2702-2710
5. Chang, T. N., Huang, S. S., Chang, Y. S., Chang, C. I., Yang, H. L., Deng, J. S., & Huang, G. J. (2011). Analgesic effects and mechanisms of anti-inflammation of taraxeren-3-one from Diospyros maritima in mice. Journal of Agricultural and Food Chemistry, 59, 9112-9119
6. Chang, S. S., Huang, H. J., & Chen, C. Y. C. (2011). High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database Taiwan. Molecular Biosystems, 7, 3366-3374
7. Chang, S. S., Huang, H. J., & Chen, C. Y. C. (2011). Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine PLoS Computational Biology, 7, e1002315
8. Chang, T. T., Sun, M. F., Chen, H. Y., Tsai, F. J., Fisher, M., Lin, J. G., & Chen, C. Y. C. (2011). Screening from the world?s largest TCM database against H1N1 virus. Journal of Biomolecular Structure & Dynamics, 28, 773-786
9. Chang, K. W., Tsai, T. Y., Chen, K. C., Yang, S. C., Huang, H. J., Chang, T. T., & Chen, C. Y. C. (2011). iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design. Journal of Biomolecular Structure & Dynamics, 29, 243-250
10. Chang, P. C., Wang, J. D., Lee, M. M., Chang, S. S., Tsai, T. Y., Chang, K. W., & Chen, C. Y. C. (2011). Lose weight with traditional chinese medicine? Potential suppression of fat mass and obesity-associated protein Journal of Biomolecular Structure & Dynamics, 29, 471-483
11. Chen, C. Y. C. (2007). The molecular dynamic simulation of zolpidem interaction with gamma aminobutyric acid type A receptor. Journal of the Chinese Chemical Society, 54, 653-658
12. Chen, C. Y. C. (2010). Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors. Journal of the Taiwan Institute of Chemical Engineers, 41, 143-149
13. Chen, C. Y. C (2011). TCM database Taiwan: The world?s largest traditional Chinese medicine database for drug screening in silico. PLoS ONE, 6, e15939
14. Chen, C. Y. C. (2012). Mechanism of BAG1 repair on Parkinson?s disease-linked DJ1 mutation. Journal of Biomolecular Structure & Dynamics, 30, 1-12
15. Chen, K. Y., Chang, S.S., & Chen, C. Y. C. (2012). In silico identification of potent pancreatic triacylglycerol lipase inhibitors from traditional Chinese medicine. PLoS ONE, 7, e43932
16. Chen, K. C., Chang, K. W., Chen, H. Y., & Chen, C. Y. C. (2011). Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? Molecular Biosystems, 7, 2711-2719
17. Chen, K. C., Chang, S. S., Huang, H. J., Lin, T. L., Wu, Y. J., & Chen, C. Y. (2012). Three-in-one agonists for PPARalpha, PPAR-gamma, and PPAR-delta from traditional Chinese medicine. Journal of Biomolecular Structure and Dynamics, 30, 662-683
18. Chen, K. C., & Chen, C. Y. C. (2011). Stroke prevention by traditional Chinese medicine? A genetic algorithm, support vector machine and molecular dynamics approach Soft Matter, 7, 4001-4008
19. Chen, C. Y.C., Chen, G. W., & Chen, W. Y. C. (2008). Molecular simulation of HER2/neu degradation by inhibiting HSP90. Journal of the Chinese Chemical Society, 55, 297-302
20. Chen, C. Y., Huang, H. J., Tsai, F. J., & Chen, C. Y.C. (2010). Drug design for Influenza A virus subtype H1N1. Journal of the Taiwan Institute of Chemical Engineers, 41, 8-15
21. Chen, K. C., Sun, M. F., Yang, S. C., Chang, S. S., Chen, H. Y., Tsai, F. J., & Chen, C. Y. C. (2011). Investigation into potent inflammation inhibitors from traditional Chinese medicine. Chemical Biology & Drug Design, 78, 679-688
22. Choi, S. Y., Ahn, E. M., Song, M. C., Kim, D. W., Kang, J. H., Kwon, O. S., & Baek, N. I. (2005). In vitro GABAtransaminase inhibitory compounds from the root of Angelica dahurica. Phytotherapy Research: PTR, 19, 839-845
23. Doi, K., Kojima, T., Makino, M., Kimura, Y., & Fujimoto, Y. (2001). Studies on the constituents of the leaves of Morus alba L. Chemical & Pharmaceutical Bulletin, 49, 151-153
24. Duckworth, W. C., Bennett, R. G., & Hamel, F. G. (1998). Insulin degradation: Progress and potential. Endocrine Reviews, 19, 608-624
25. Fletcher, R. (1969). Optimization. New York, NY: Academic Press.
26. Fletcher, R., & Reeves, C. M. (1964). Function minimization by conjugate gradients. Computer Journal, 7, 149-154
27. Florez, J. C., Wiltshire, S., Agapakis, C. M., Burtt, N. P., de Bakker, P. I., Almgren, P., & Groop, L. (2006). High-density haplotype structure and association testing of the insulin-degrading enzyme (IDE) gene with type 2 diabetes in 4,206 people. Diabetes, 55, 128-135
28. Groves, C. J., Wiltshire, S., Smedley, D., Owen, K. R., Frayling, T. M., Walker, M., & McCarthy, M. I. (2003). Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes, 52, 1300-1305
29. Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4, 435-447
30. Hu, C., Wang, C., Zhang, R., Ma, X., Wang, J., Lu, J., & Jia, W. (2009). Variations in KCNQ1 are associated with type 2 diabetes and beta cell function in a Chinese population. Diabetologia, 52, 1322-1325
31. Huang, H. J., Yu, H. W., Chen, C. Y., Hsu, C. H., Chen, H. Y., Lee, K. J., & Chen, C. Y.C. (2010). Current developments of computer-aided drug design. Journal of the Taiwan Institute of Chemical Engineers, 41, 623-635
32. Im, H., Manolopoulou, M., Malito, E., Shen, Y., Zhao, J., Neant-Fery, M., & Tang, W. J. (2007). Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. The Journal of Biological Chemistry, 282, 25453-25463
33. Jirovsky, D., Kosina, P., Myslinova, M., Styskala, J., Ulrichova, J., & Simanek, V. (2007). HPLC analysis of rosmarinic acid in feed enriched with aerial parts of Prunella vulgaris and its metabolites in pig plasma using dual-channel coulometric detection. Journal of Agricultural and Food Chemistry, 55, 7631-7637
34. Karamohamed, S., Demissie, S., Volcjak, J., Liu, C., Heard-Costa, N., Liu, J., & Herbert, A. (2003). Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham heart study. Diabetes, 52, 1562-1567
35. Kuo, W. L., Gehm, B. D., & Rosner, M. R. (1991). Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway. Molecular Endocrinology, 5, 1467-1476
36. Leissring, M. A., Malito, E., Hedouin, S., Reinstatler, L., Sahara, T., Abdul-Hay, S. O., & Selkoe, D. J. (2010). Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE, 5, e10504
37. Lin, C. H., Chang, T. T., Sun, M. F., Chen, H. Y., Tsai, F. J., Chang, K. L., & Chen, C. Y. C. (2011). Potent inhibitor design against H1N1 swine influenza: Structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database. Journal of Biomolecular Structure & Dynamics, 28, 471-482
38. Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46, 3-26
39. Perlman, R. K., Gehm, B. D., Kuo, W. L., & Rosner, M. R. (1993). Functional analysis of conserved residues in the active site of insulin-degrading enzyme. The Journal of Biological Chemistry, 268, 21538-21544
40. Qian, Y., Lu, F, Dong, M, Lin, Y, Li, H, Chen, J, & Shen, H. (2012). Genetic variants of IDE-KIF11-HHEX at 10q23.33 associated with type 2 diabetes risk: a fine-mapping study in Chinese population. PLoS ONE, 7, e35060
41. Ronn, T., Wen, J., Yang, Z., Lu, B., Du, Y., Groop, L., & Ling, C. (2009). A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia, 52, 830-833
42. Shen, Y., Joachimiak, A., Rosner, M. R., & Tang, W. J. (2006). Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature, 443, 870-874
43. Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005). Type 2 diabetes: principles of pathogenesis and therapy. Lancet, 365, 1333-1346
44. Sun, M. F., Chang, T. T., Chang, K. W., Huang, H. J., Chen, H. Y., Tsai, F. J., & Chen, C. Y. C. (2011). Blocking the DNA repair system by traditional Chinese medicine? Journal of Biomolecular Structure & Dynamics, 28, 895-906
45. Sun, M. F., Chen, H. Y., Tsai, F. J., Liu, S. H., Chen, C. Y., & Chen, C. Y.C. (2011). Search for novel remedies to augment radiation resistance of inhabitants of Fukushima and Chernobyl disasters: Identifying DNA repair protein XRCC4 inhibitors. Journal of Biomolecular Structure & Dynamics, 29, 325-337
46. Tou, W. I., & Chen, C. Y. C. (2012). Traditional Chinese medicine as dual guardians against hypertension and cancer? Journal of Biomolecular Structure and Dynamics, 30, 299-317
47. Tou, W. I., & Chen, C. Y. (2012). In silico investigation of potential SRC kinase ligands from traditional Chinese medicine. PLoS ONE, 7, e33728
48. Tsai, T. Y., Chang, K. W., & Chen, C. Y. C. (2011). IScreen: world?s first cloud-computing web server for virtual screening and de novo drug design based on TCM database Taiwan. Journal of Computer-Aided Molecular Design, 25, 525-531
49. Tsai, K. N., Chen, G. W., & Chen, C. Y. C. (2012). A novel algorithm for identification of activated cryptic 5? splice sites. Journal of Biomolecular Structure & Dynamics, 29, 1089-1099
50. Tsai, F. J., Yang, C. F., Chen, C. C., Chuang, L. M., Lu, C. H., Chang, C. T., & Wu, J. Y. (2010). A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genetics, 6, e1000847
51. Valentova, K., Truong, N. T., Moncion, A., de Waziers, I., & Ulrichova, J. (2007). Induction of glucokinase mRNA by dietary phenolic compounds in rat liver cells in vitro. Journal of Agricultural and Food Chemistry, 55, 7726-7731
52. Venkatachalam, C. M., Jiang, X., Oldfield, T., & Waldman, M. (2003). LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics and Modelling, 21, 289-307
53. Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, 8, 127-134
54. Wang, C., Hu, C., Zhang, R., Bao, Y., Ma, X., Lu, J., & Jia, W. (2009). Common variants of hepatocyte nuclear factor 1beta are associated with type 2 diabetes in a Chinese population. Diabetes, 58, 1023-1027
55. Wen, J., Ronn, T., Olsson, A., Yang, Z., Lu, B., Du, Y. P., & Hu, R. M. (2010). Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS ONE, 5, e9153
56. Wu, Y., Li, H. X., Loos, R. J.F., Yu, Z. J., Ye, X. W., Chen, L. H., & Lin, X. (2008). Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes, 57, 2834-2842
57. Yang, S. C., Chang, S. S., & Chen, C. Y. C. (2011). Identifying HER2 inhibitors from natural products database. PLoS ONE, 6, e28793
58. Yang, S. C., Chang, S. S., Chen, H. Y., & Chen, C. Y. C. (2011). Identification of potent EGFR inhibitors from TCM Database Taiwan. PLoS Computational Biology, 7, e1002189
59. Yang, C. P., Huang, G. J., Huang, H. C., Chen, Y. C., Chang, C. I., Wang, S. Y., & Kuo, Y. H. (2012). A new butanolide compound from the aerial part of Lindera akoensis with anti-inflammatory activity. Molecules, 17, 6585-6592
60. Zheng, J., He, J., Ji, B., Li, Y., & Zhang, X. (2007). Antihyperglycemic activity of Prunella vulgaris L. in streptozotocininduced diabetic mice. Asia Pacific Journal of Clinical Nutrition, 16(1), 427-431
61. Zhou, D. Z., Zhang, D., Liu, Y., Zhao, T., Chen, Z., Liu, Z., & He, L. (2009). The E23K variation in the KCNJ11 gene is associated with type 2 diabetes in Chinese and East Asian population. Journal of Human Genetics, 54, 433-435